BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bocelli-tyndall C, Trella E, Frachet A, Zajac P, Pfaff D, Geurts J, Heiler S, Barbero A, Mumme M, Resink TJ, Schaeren S, Spagnoli GC, Tyndall A. FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Ann Rheum Dis 2014;74:260-6. [DOI: 10.1136/annrheumdis-2013-204235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 López-García L, Castro-Manrreza ME. TNF-α and IFN-γ Participate in Improving the Immunoregulatory Capacity of Mesenchymal Stem/Stromal Cells: Importance of Cell-Cell Contact and Extracellular Vesicles. Int J Mol Sci 2021;22:9531. [PMID: 34502453 DOI: 10.3390/ijms22179531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Montesinos JJ, López-García L, Cortés-Morales VA, Arriaga-Pizano L, Valle-Ríos R, Fajardo-Orduña GR, Castro-Manrreza ME. Human Bone Marrow Mesenchymal Stem/Stromal Cells Exposed to an Inflammatory Environment Increase the Expression of ICAM-1 and Release Microvesicles Enriched in This Adhesive Molecule: Analysis of the Participation of TNF-α and IFN-γ. J Immunol Res 2020;2020:8839625. [PMID: 33335929 DOI: 10.1155/2020/8839625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, Ni Z, Zhang B, Zhang D, Luo F, Chen H, Sun X, Feng JQ, Qi H, Chen L. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther 2020;5:181. [PMID: 32879300 DOI: 10.1038/s41392-020-00222-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 109] [Article Influence: 16.5] [Reference Citation Analysis]
4 Qiu X, Zhuang M, Lu Z, Liu Z, Cheng D, Zhu C, Liu J. RIPK1 suppresses apoptosis mediated by TNF and caspase-3 in intervertebral discs. J Transl Med 2019;17:135. [PMID: 31029152 DOI: 10.1186/s12967-019-1886-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lu W, Gao B, Fan J, Cheng P, Hu Y, Jie Q, Luo Z, Yang L. Mesenchymal Progenitors Derived from Different Locations in Long Bones Display Diverse Characteristics. Stem Cells Int 2019;2019:5037578. [PMID: 31089329 DOI: 10.1155/2019/5037578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Karlsen TA, Brinchmann JE. Expression of inflammatory cytokines in mesenchymal stromal cells is sensitive to culture conditions and simple cell manipulations. Exp Cell Res 2019;374:122-7. [PMID: 30496759 DOI: 10.1016/j.yexcr.2018.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
7 Martin C, Olmos É, Collignon M, De Isla N, Blanchard F, Chevalot I, Marc A, Guedon E. Revisiting MSC expansion from critical quality attributes to critical culture process parameters. Process Biochemistry 2017;59:231-43. [DOI: 10.1016/j.procbio.2016.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lu C, Gao S, Xu G. Geraniin inhibits TNF-α-induced impairments of osteogenesis through NF-κB and p38 MAPK signalling pathways in bone marrow stem cells. Stroke Vasc Neurol 2017;2:47-52. [PMID: 28959491 DOI: 10.1136/svn-2016-000046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Schena F, Menale C, Caci E, Diomede L, Palagano E, Recordati C, Sandri M, Tampieri A, Bortolomai I, Capo V, Pastorino C, Bertoni A, Gattorno M, Martini A, Villa A, Traggiai E, Sobacchi C. Murine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector. Stem Cells 2017;35:1365-77. [PMID: 28100034 DOI: 10.1002/stem.2574] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
10 Tyndall A, van Laar JM. Stem cell transplantation and mesenchymal cells to treat autoimmune diseases. Presse Med. 2016;45:e159-e169. [PMID: 27256975 DOI: 10.1016/j.lpm.2016.05.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
11 Rosenblatt-Velin N, Badoux S, Liaudet L. Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? Stem Cells Int 2016;2016:5961342. [PMID: 26880973 DOI: 10.1155/2016/5961342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
12 Sousa MFQ, Silva MM, Giroux D, Hashimura Y, Wesselschmidt R, Lee B, Roldão A, Carrondo MJT, Alves PM, Serra M. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes. Biotechnol Progress 2015;31:1600-12. [DOI: 10.1002/btpr.2158] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
13 Tyndall A. Mesenchymal stromal cells and rheumatic disorders. Immunol Lett 2015;168:201-7. [PMID: 26142543 DOI: 10.1016/j.imlet.2015.05.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]